Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Passage Bio Inc (PASG)

Passage Bio Inc (PASG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 73,934
  • Shares Outstanding, K 61,612
  • Annual Sales, $ 0 K
  • Annual Income, $ -102,060 K
  • 60-Month Beta 1.30
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.61
Trade PASG with:

Options Overview Details

View History
  • Implied Volatility 685.73% ( +449.28%)
  • Historical Volatility 94.76%
  • IV Percentile 85%
  • IV Rank 46.42%
  • IV High 1,425.22% on 02/09/24
  • IV Low 44.99% on 01/17/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 90
  • Volume Avg (30-Day) 37
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 1,099
  • Open Int (30-Day) 1,051

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.37
  • Number of Estimates 2
  • High Estimate -0.33
  • Low Estimate -0.41
  • Prior Year -0.63
  • Growth Rate Est. (year over year) +41.27%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.1201 +2.67%
on 04/19/24
1.6100 -28.57%
on 03/21/24
-0.2500 (-17.86%)
since 03/19/24
3-Month
0.8405 +36.82%
on 01/25/24
1.7900 -35.75%
on 03/06/24
+0.2511 (+27.93%)
since 01/19/24
52-Week
0.5751 +99.97%
on 11/13/23
1.7900 -35.75%
on 03/06/24
+0.1200 (+11.65%)
since 04/19/23

Most Recent Stories

More News
Newman Ferrara LLP Announces Corporate Governance Investigations of Passage Bio, Inc. (PASG)

Newman Ferrara LLP announced today that the firm is conducting investigations on behalf of shareholders of Passage Bio, Inc. (NASDAQ: PASG) (“Passage” or the “Company”). The investigations concern...

PASG : 1.1500 (-4.17%)
Passage Bio Doses First Patient in Global Clinical Trial of PBFT02 Gene Therapy for Frontotemporal Dementia with Granulin Mutations

PHILADELPHIA, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing...

PASG : 1.1500 (-4.17%)
Passage Bio to Present at 2022 Wedbush PacGrow Healthcare Virtual Conference

PHILADELPHIA, Aug. 05, 2022 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing...

PASG : 1.1500 (-4.17%)
Passage Bio Reports Second Quarter 2022 Financial Results and Provides Recent Business Highlights

Advanced Imagine-1 clinical trial for GM1 gangliosidosis to recruitment of final cohort, Cohort 4, in dose-ascending phase of study following...

PASG : 1.1500 (-4.17%)
Passage Bio to Report Second Quarter 2022 Financial Results on August 4, 2022

PHILADELPHIA, July 28, 2022 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing...

PASG : 1.1500 (-4.17%)
Passage Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

PHILADELPHIA, July 21, 2022 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing...

PASG : 1.1500 (-4.17%)
Passage Bio Appoints Michael Kamarck, Ph.D. to Board of Directors

PHILADELPHIA, July 06, 2022 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing...

PASG : 1.1500 (-4.17%)
Passage Bio to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference

PHILADELPHIA, June 09, 2022 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing...

PASG : 1.1500 (-4.17%)
Passage Bio Receives FDA Clearance of IND Application for PBML04 for Treatment of Metachromatic Leukodystrophy

• PBML04 represents the company’s fourth program to receive IND clearance PHILADELPHIA, June 08, 2022 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (Nasdaq:...

PASG : 1.1500 (-4.17%)
Passage Bio Announces Leadership Transition

Bruce Goldsmith, Ph.D. to step down as president and chief executive officer and member of board of directors, will serve as a strategic advisor for a...

PASG : 1.1500 (-4.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Passage Bio Inc. is a genetic medicines company. It is focused on developing transformative therapies for rare, monogenic central nervous system diseases. The company's principal product includes GM1 gangliosidosis, frontotemporal dementia and Krabbe disease which is in clinical stage. Passage Bio Inc....

See More

Key Turning Points

3rd Resistance Point 1.2732
2nd Resistance Point 1.2366
1st Resistance Point 1.1933
Last Price 1.1500
1st Support Level 1.1134
2nd Support Level 1.0768
3rd Support Level 1.0335

See More

52-Week High 1.7900
Fibonacci 61.8% 1.3259
Fibonacci 50% 1.1825
Last Price 1.1500
Fibonacci 38.2% 1.0392
52-Week Low 0.5751

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar